Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Discovery Program...
View:
Post by Harper75 on Aug 30, 2023 4:05pm

Discovery Program...

I'm anxiously awaiting the upcoming (Q3/2023) announcement on the Discovery Program but I'm tempering my expectation of ANY market reaction considering the lack of market interest at the present time.  I'm hopful this is material padding to their bench strength and adding IC value needing to be taken into account after Phase II results are published.  Still hopefull for an acquistion post Phase II
Comment by Harper75 on Aug 30, 2023 4:17pm
Managed to spell hopeful incorrectly TWICE in the same post - can't even blame 4:20
Comment by MrMugsy on Aug 30, 2023 6:03pm
I am also curious about the discovery program.  Sure hope it's around Ketorolac.  That would explain a lot of things right now. Regardless - to your point, likely makes no difference to share price. Needle moves on OTENA's success in P2 (or on P2 expectations). Hoping that partnering or an acquisition revolves around OTENA only. Just not worth negotiating anything else until ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities